SHEDIR PHARMA GROUP revenue for the last year amounted to 60.20 M EUR, the most of which — 48.35 M EUR — came from its highest performing source at the moment, Marketing of Supplements, Medical Devices and Dermocosmetics, the year earlier bringing 40.96 M EUR. The greatest contribution to the revenue figure was made by Italy — last year it brought SHEDIR PHARMA GROUP 54.59 M EUR, and the year before that — 45.62 M EUR.